Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACT NYSEARCA:BTEK BATS:HELX NYSEARCA:MSOX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTEnact$35.13+1.1%$35.68$30.79▼$37.97$5.22B0.57318,584 shs416,905 shsBTEKBlackRock Future Tech ETF$23.18$23.18$18.92▼$28.67$13.91M1.643,762 shsN/AHELXFranklin Genomic Advancements ETF$27.86+2.6%$27.41$23.74▼$33.93$11.02M1.053,767 shs2,058 shsMSOXAdvisorShares MSOX 2X Daily ETF$4.06+17.0%$3.04$2.14▼$58.80$16.96M3.97324,701 shs1.29 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTEnact+1.06%-0.28%-6.42%-5.87%+3.23%BTEKBlackRock Future Tech ETF0.00%0.00%0.00%0.00%-10.19%HELXFranklin Genomic Advancements ETF+0.41%-1.61%-0.27%+1.24%-17.17%MSOXAdvisorShares MSOX 2X Daily ETF+17.00%-3.33%+45.00%-12.69%-93.05%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACTEnactN/AN/AN/AN/AN/AN/AN/AN/ABTEKBlackRock Future Tech ETFN/AN/AN/AN/AN/AN/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACTEnact 0.00N/AN/AN/ABTEKBlackRock Future Tech ETF 2.77Moderate Buy$23.18N/AHELXFranklin Genomic Advancements ETF 2.75Moderate Buy$27.86N/AMSOXAdvisorShares MSOX 2X Daily ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HELX, MSOX, BTEK, and ACT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025ACTEnactJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$37.00 ➝ $39.007/7/2025ACTEnactKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$39.00 ➝ $40.005/5/2025ACTEnactUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$38.00 ➝ $40.005/5/2025ACTEnactKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$39.00 ➝ $39.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACTEnact$1.20B4.39$4.73 per share7.43$34.81 per share1.01BTEKBlackRock Future Tech ETFN/AN/AN/AN/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACTEnact$688.07M$4.398.007.652.1255.35%13.61%10.42%N/ABTEKBlackRock Future Tech ETFN/AN/A42.91∞N/AN/AN/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/A26.71∞N/AN/AN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/A0.00∞N/AN/AN/AN/AN/ALatest HELX, MSOX, BTEK, and ACT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025ACTEnact$1.11$1.15+$0.04$1.11$307.54 million$304.89 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACTEnact$0.842.39%N/A19.13%3 YearsBTEKBlackRock Future Tech ETFN/A0.00%N/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/A0.00%N/AN/AN/ALatest HELX, MSOX, BTEK, and ACT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/30/2025ACTEnactquarterly$0.212.44%8/18/20258/18/20259/8/20255/19/2025ACTEnactquarterly$0.212.35%5/19/20255/19/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACTEnact0.141.091.13BTEKBlackRock Future Tech ETFN/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACTEnact18.03%BTEKBlackRock Future Tech ETFN/AHELXFranklin Genomic Advancements ETFN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AInsider OwnershipCompanyInsider OwnershipACTEnact0.44%BTEKBlackRock Future Tech ETFN/AHELXFranklin Genomic Advancements ETFN/AMSOXAdvisorShares MSOX 2X Daily ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACTEnact500150.07 million149.41 millionNot OptionableBTEKBlackRock Future Tech ETFN/A600,000N/ANot OptionableHELXFranklin Genomic Advancements ETFN/A400,000N/ANot OptionableMSOXAdvisorShares MSOX 2X Daily ETFN/A4.18 millionN/ANot OptionableHELX, MSOX, BTEK, and ACT HeadlinesRecent News About These CompaniesTop Performing Leveraged/Inverse ETFs: 07/27/2025July 29, 2025 | etftrends.comETop Performing Leveraged/Inverse ETFs: 07/13/2025July 15, 2025 | etftrends.comETop Performing Leveraged/Inverse ETFs: 04/20/2025April 22, 2025 | etftrends.comEBest Leveraged ETFs of Last WeekApril 22, 2025 | zacks.comStarlight Capital Launches SCNA ETF, Bringing High-Quality North American Growth to InvestorsMarch 21, 2025 | theglobeandmail.comTrump’s Targeted Tariffs On Aluminum & Steel: A Potential Boon For U.S. Material ETFsFebruary 11, 2025 | theglobeandmail.com(MSOX) Trading SignalsJanuary 22, 2025 | news.stocktradersdaily.comN(MSOX) Trading ReportJanuary 12, 2025 | news.stocktradersdaily.comNTop Performing Leveraged/Inverse ETFs: 01/05/2025January 10, 2025 | etftrends.comE(MSOX) Technical DataDecember 21, 2024 | news.stocktradersdaily.comN(MSOX) Investment Analysis and AdviceDecember 11, 2024 | news.stocktradersdaily.comNTop Performing Leveraged/Inverse ETFs: 12/01/2024December 4, 2024 | etftrends.comEAdvisorShares Announces Reverse Split For MSOS Daily Leveraged ETF, What Investors Need To KnowNovember 18, 2024 | benzinga.comTrex 2x Long Nflx Daily Target Etf Share Price (NFLU.US)October 7, 2024 | lse.co.uk5 Best Leveraged ETFs of SeptemberOctober 1, 2024 | zacks.comMSTU T-Rex 2X Long MSTR Daily Target ETFSeptember 28, 2024 | seekingalpha.comMicroStrategy 2X Leveraged ETF Sees Massive Inflows In First Week Of Trading As MSTR Outperforms BitcoinSeptember 27, 2024 | coindesk.comTidal Trust II - Defiance Daily Target 2X Long AVGO ETFAugust 24, 2024 | money.usnews.comTidal Trust II - Defiance Daily Target 2x Long SMCI ETFAugust 24, 2024 | money.usnews.comMSOX Advisorshares Msos 2x Daily ETFAugust 16, 2024 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHELX, MSOX, BTEK, and ACT Company DescriptionsEnact NASDAQ:ACT$35.13 +0.37 (+1.06%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$35.14 +0.00 (+0.01%) As of 08/1/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.BlackRock Future Tech ETF NYSEARCA:BTEK$23.18 0.00 (0.00%) As of 08/15/2024The BlackRock Future Tech ETF (BTEK) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities involved in the technology sector. BTEK was launched on Sep 29, 2020 and is managed by BlackRock.Franklin Genomic Advancements ETF BATS:HELX$27.86 +0.70 (+2.59%) Closing price 08/1/2025 03:58 PM EasternExtended Trading$27.86 0.00 (-0.02%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.AdvisorShares MSOX 2X Daily ETF NYSEARCA:MSOX$4.06 +0.59 (+17.00%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$4.12 +0.06 (+1.38%) As of 08/1/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Advisorshares Msos 2x Daily ETF (MSOX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund-of-fund that seeks to achieve 2x the daily total return of the AdvisorShares Pure US Cannabis ETF (MSOS) through swap agreements. MSOX was launched on Aug 23, 2022 and is managed by AdvisorShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
